Research paperNitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.
Under a Creative Commons license
open access
Keywords
COVID-19
Nitazoxanide
Randomized controlled clinical trial
Lymphocytes cell activation markers
Interleukins
Cited by (0)
© 2021 The Authors. Published by Elsevier Ltd.